WuXi Biologics (2269)

65.25
-1.75(-2.61%)
  • Volume:
    39,669,822
  • Bid/Ask:
    65.25/65.30
  • Day's Range:
    64.15 - 66.20

2269 Historical Data

Time Frame:
Daily
01/03/2023 - 01/31/2023
65.2565.7066.2064.1539.67M-2.61%
65.2565.7066.2064.1539.67M-2.61%
67.0070.9571.1066.3542.28M-5.57%
67.0070.9571.1066.3542.28M-5.57%
70.9571.4072.0069.8511.48M-0.63%
70.9571.4072.0069.8511.48M-0.63%
71.4072.1572.5069.7014.40M+0.07%
71.4072.1572.5069.7014.40M+0.07%
71.3571.0072.1069.9013.22M+1.35%
71.3571.0072.1069.9013.22M+1.35%
70.4068.2571.5067.7015.83M+1.51%
70.4068.2571.5067.7015.83M+1.51%
69.3568.7570.1067.2528.49M-0.07%
69.3568.7570.1067.2528.49M-0.07%
69.4072.0072.0068.60108.78M-6.09%
69.4072.0072.0068.60108.78M-6.09%
73.9072.6077.4071.0044.58M+1.79%
73.9072.6077.4071.0044.58M+1.79%
72.6069.0572.9068.6028.82M+6.37%
72.6069.0572.9068.6028.82M+6.37%
68.2571.0071.5567.4036.57M-2.43%
68.2571.0071.5567.4036.57M-2.43%
69.9568.0573.3068.0046.92M+7.20%
69.9568.0573.3068.0046.92M+3.78%
67.4068.0068.6566.9016.59M-0.37%
67.6567.1069.0066.7024.76M+2.42%
66.0568.1068.2065.0024.55M-2.15%
67.5068.4071.3066.4044.79M+1.96%
66.2063.3566.3061.6037.72M+5.84%
62.5558.6063.9558.5534.21M+4.51%
Highest: 77.40Lowest: 58.55Difference: 18.85Average: 69.23Change %: 9.02
  • Nomura Axes WUXI BIO TP to $95.75, Rating Buy
    0
    • What’s happen?
      0
      • M Stanley Foresees WUXI BIO Shr Rise in 30 Days, Rated Overweight with $175 TP
        0
        • Daiwa Adds WUXI BIO TP to $167; Rated*** ***Buy
          0
          • C Suisse Hikes WUXI BIO TP to $158, Rated ***Outperform***
            0
            • Goldman Sachs Increases TP to $131.4 Rated BUY ! 👍🏻
              0
              • JPM Hikes WUXI BIO TP to $130; Rated ***Overweight***
                0
                • Nomura Chops WUXI BIO TP to $116.8, Rated ***Buy***
                  1
                  • Definitely will back to 120 by end of this year. Company future is very good. Next factory to be setup to increase capacity expansion is ongoing till 2023. Stay tune for the extraordinary earning in the coning years. Surely a high growth positive cashflow company in China 👍🏻
                    0
                    • Daiwa: WUXI BIO ( Share Correction Overdone Entails Bottom-fish Odds, Restated ***Buy***
                      0